ZBH monthly performance report
Check ZBH's monthly returns, drawdown, and seasonality trends — updated every month.
ZBH monthly report
—
Key takeaways
- Zimmer Biomet (ZBH) closed November 2026 at $104.56, up 10.62% for the month and +16.14% over the trailing 12 months.
- Year-to-date, ZBH is +16.28%, outperforming the S&P 500 which has returned +11.03% YTD.
- The stock is trading +13.19% versus its 200-day moving average ($92.37), a bullish technical signal.
- Over the past three years, ZBH has underperformed the S&P 500 by −72.65%, with a relative strength index reading of 57.4.
- Win rate over the trailing 39 months stands at 46.2% — 18 positive months versus 21 negative months.
Zimmer Biomet ended November 2026 at $104.56, posting a monthly return of +10.62%. The S&P 500 returned +0.19% over the same window, leaving relative performance at +10.44%.
The current quarter stands at +17.71% (Q4 2026 (QTD)), while medium-term trend remains constructive: price is +13.19% versus the 200-day moving average ($92.37).
Year-to-date, ZBH is +16.28% against SPY +11.03%, a gap of +5.25%. The stock is currently −7.09% below its 52-week high, with maximum 3-year drawdown at −39.99%.
| Period | ZBH | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −2.71% | −0.35% | −2.35% |
| 1 Week | −2.14% | +3.29% | −5.43% |
| 1 Month | +10.62% | +0.19% | +10.44% |
| 3 Months | +5.01% | −2.48% | +7.49% |
| 6 Months | +25.42% | +2.00% | +23.42% |
| YTD | +16.28% | +11.03% | +5.25% |
| 12 Months | +16.14% | +10.79% | +5.35% |
| 3 Years | −0.82% | +71.83% | −72.65% |
| Rank | Month | Return |
|---|---|---|
| #1 | Aug 2025 | +15.77% |
| #2 | Feb 2026 | +13.06% |
| #3 | Nov 2023 | +11.40% |
| #4 | Nov 2026 | +10.62% |
| #5 | Jul 2026 | +9.11% |
| Rank | Month | Return |
|---|---|---|
| #1 | Sep 2026 | −11.21% |
| #2 | May 2025 | −10.56% |
| #3 | Apr 2025 | −8.95% |
| #4 | Apr 2024 | −8.86% |
| #5 | Apr 2026 | −8.84% |
| Quarter | Return |
|---|---|
| Q3 2025 | +7.99% |
| Q4 2025 | −8.71% |
| Q1 2026 | +0.56% |
| Q2 2026 | −4.79% |
| Q3 2026 | +3.18% |
| Q4 2026 (QTD) | +17.71% |
| Year | Return |
|---|---|
| 2023 | −4.55% |
| 2024 | −13.20% |
| 2025 | −14.87% |
| 2026 | +16.28% |
| Metric | Value |
|---|---|
| 52-Week High | $112.54 (2026-11-04) |
| 52-Week Low | $79.12 (2026-05-11) |
| Current Price | $104.56 |
| 200-Day Moving Average | $92.37 |
| Price vs 200DMA | +13.19% |
| 3-Year Maximum Drawdown | −39.99% (2026-05-11) |
| Current Drawdown from 52W High | −7.09% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 57.4 |
| 3-Year Excess Return vs S&P 500 | −72.65% |
| RS Peak | 108.2 (Jan 2024) |
| RS Trough | 44.8 (May 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was ZBH's return for this report period?
ZBH returned +10.62% in the latest monthly window ending 2026-11-12.
Has ZBH outperformed SPY year to date?
YTD ZBH: +16.28% vs SPY: +11.03%.
What is ZBH's 12-month return?
+16.14% over the trailing 12 months.
Is ZBH above or below its 200-day moving average?
Price is +13.19% versus 200DMA ($92.37).
What is the maximum drawdown in the 3-year window?
−39.99% on 2026-05-11.